- Home
- AIRI vs TXMD Comparison
AIRI vs TXMD Comparison
Compare AIRI & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRI
- TXMD
- Stock Information
- Founded
- AIRI 1979
- TXMD 2008
- Country
- AIRI United States
- TXMD United States
- Employees
- AIRI N/A
- TXMD N/A
- Industry
- AIRI Military/Government/Technical
- TXMD Biotechnology: Pharmaceutical Preparations
- Sector
- AIRI Industrials
- TXMD Health Care
- Exchange
- AIRI Nasdaq
- TXMD Nasdaq
- Market Cap
- AIRI 15.4M
- TXMD 13.1M
- IPO Year
- AIRI N/A
- TXMD N/A
- Fundamental
- Price
- AIRI $4.35
- TXMD $1.16
- Analyst Decision
- AIRI
- TXMD
- Analyst Count
- AIRI 0
- TXMD 0
- Target Price
- AIRI N/A
- TXMD N/A
- AVG Volume (30 Days)
- AIRI 45.8K
- TXMD 18.0K
- Earning Date
- AIRI 11-14-2024
- TXMD 11-12-2024
- Dividend Yield
- AIRI N/A
- TXMD N/A
- EPS Growth
- AIRI N/A
- TXMD N/A
- EPS
- AIRI N/A
- TXMD N/A
- Revenue
- AIRI $53,657,000.00
- TXMD $1,596,000.00
- Revenue This Year
- AIRI $9.26
- TXMD $605.07
- Revenue Next Year
- AIRI $8.73
- TXMD $1.11
- P/E Ratio
- AIRI N/A
- TXMD N/A
- Revenue Growth
- AIRI 3.31
- TXMD N/A
- 52 Week Low
- AIRI $3.00
- TXMD $1.10
- 52 Week High
- AIRI $9.44
- TXMD $2.75
- Technical
- Relative Strength Index (RSI)
- AIRI 38.83
- TXMD 29.78
- Support Level
- AIRI $4.11
- TXMD $1.10
- Resistance Level
- AIRI $4.60
- TXMD $1.30
- Average True Range (ATR)
- AIRI 0.26
- TXMD 0.06
- MACD
- AIRI 0.02
- TXMD -0.01
- Stochastic Oscillator
- AIRI 30.77
- TXMD 21.21
About AIRI Air Industries Group
Air Industries Group is an aerospace and defense company. Its manufactures and designs structural parts and assemblies that focus on flight safety, including landing gear, arresting gear, engine mounts, flight controls, throttle quadrants, jet engines, and other components. The company also provides sheet metal fabrication of aerostructures, tube bending, and welding services.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.